Back to Search Start Over

Vitamin C and folate status in hereditary fructose intolerance

Authors :
Pediatría
Pediatria
Cano San José, Ainara
Alcalde, Carlos
Belanger Quintana, Amaya
Cañedo Villarroya, Elvira
Ceberio, Leticia
Chumillas Calzada, Silvia
Correcher, Patricia
Couce, María Luz
García Arenas, Dolores
Gómez, Igor
Hernández, Tomás
Izquierdo García, Elsa
Martínez Chicano, Dámaris
Morales, Montserrat
Pedrón Giner, Consuelo
Petrina Jáuregui, Estrella
Peña Quintana, Luis
Sánchez Pintos, Paula
Serrano Nieto, Juliana
Unceta Suárez, María
Vitoria Miñana, Isidro
De las Heras Montero, Javier Adolfo
Pediatría
Pediatria
Cano San José, Ainara
Alcalde, Carlos
Belanger Quintana, Amaya
Cañedo Villarroya, Elvira
Ceberio, Leticia
Chumillas Calzada, Silvia
Correcher, Patricia
Couce, María Luz
García Arenas, Dolores
Gómez, Igor
Hernández, Tomás
Izquierdo García, Elsa
Martínez Chicano, Dámaris
Morales, Montserrat
Pedrón Giner, Consuelo
Petrina Jáuregui, Estrella
Peña Quintana, Luis
Sánchez Pintos, Paula
Serrano Nieto, Juliana
Unceta Suárez, María
Vitoria Miñana, Isidro
De las Heras Montero, Javier Adolfo
Publication Year :
2022

Abstract

Background Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients. Methods Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls. Results Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001). Conclusions Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.

Details

Database :
OAIster
Notes :
This work was supported by Exp. No. 2018111095, Basque Government, Health Department; FEDER, the Spanish Federation for Rare Diseases (FI18053); and Danone-Nutricia-Metabolics, which was not involved in the study hypothesis/design, execution, analysis, or interpretation., English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1376895600
Document Type :
Electronic Resource